dacarbazine has been researched along with iofetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kan, S; Miyasaka, Y; Murata, K; Ohbu, M; Saito, M; Takagi, H; Takano, S; Yada, K | 1 |
| Doi, H; Iizuka, H; Ishida-Yamamto, A; Ito, Y; Tsuji, H | 1 |
2 other study(ies) available for dacarbazine and iofetamine
| Article | Year |
|---|---|
[Primary intracranial melanoma: a case report].
Topics: Adult; Amphetamines; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Dacarbazine; Diagnosis, Differential; Humans; Interferon-beta; Iodine Radioisotopes; Iofetamine; Magnetic Resonance Imaging; Male; Melanoma; Nimustine; Prognosis; Tomography, Emission-Computed, Single-Photon; Vincristine | 1992 |
Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cisplatin; Dacarbazine; Fatal Outcome; Female; Humans; Interferon-beta; Iofetamine; Liver Neoplasms; Lung Neoplasms; MART-1 Antigen; Mastectomy, Modified Radical; Melanoma; Middle Aged; Neoplasm Staging; Nimustine; Nipples; Radiopharmaceuticals; S100 Proteins; Skin Neoplasms; Tamoxifen; Tomography, Emission-Computed, Single-Photon; Vincristine | 2010 |